Stay updated on CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial
Sign up to get notified when there's something new on the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page.

Latest updates to the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page
- Check6 days agoChange DetectedA minor revision update was applied to the site, updating the revision tag from v3.5.4 to v3.5.5, signaling a small behind-the-scenes update.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, signaling a minor maintenance release rather than a substantive update to content or features.SummaryDifference0.1%

- Check41 days agoChange DetectedThe revision label on the page was updated to v3.5.3, replacing the prior v3.5.2, which reflects a new build of the page.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check77 days agoChange DetectedA new Revision: v3.5.0 label appears, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check91 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3 in the footer. This is a metadata update and does not affect study details or user actions.SummaryDifference0.1%

Stay in the know with updates to CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page.